Perfil
Ann Beliën is the founder of Rejuvenate Biomed.
She held the title of Chief Executive Officer & Director at the company.
Cargos activos de Ann Beliën
Empresas | Cargo | Inicio |
---|---|---|
Rejuvenate Biomed
Rejuvenate Biomed Medical/Nursing ServicesHealth Services Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation. | Fundador | - |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Rejuvenate Biomed
Rejuvenate Biomed Medical/Nursing ServicesHealth Services Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation. | Health Services |
- Bolsa de valores
- Insiders
- Ann Beliën